Adage Capital Partners GP L.L.C. Has $1.29 Million Position in Alignment Healthcare, Inc. $ALHC

Adage Capital Partners GP L.L.C. raised its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 101.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 69,497 shares of the company's stock after acquiring an additional 35,000 shares during the quarter. Adage Capital Partners GP L.L.C.'s holdings in Alignment Healthcare were worth $1,294,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of ALHC. MCF Advisors LLC grew its stake in Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after acquiring an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new position in Alignment Healthcare during the 1st quarter valued at about $42,000. Amalgamated Bank grew its stake in Alignment Healthcare by 21.6% during the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after acquiring an additional 616 shares in the last quarter. Voloridge Investment Management LLC purchased a new position in Alignment Healthcare during the 4th quarter valued at about $189,000. Finally, Regal Partners Ltd bought a new stake in shares of Alignment Healthcare in the 1st quarter valued at approximately $194,000. Hedge funds and other institutional investors own 86.19% of the company's stock.

Insider Buying and Selling

In other news, Director Joseph S. Konowiecki sold 25,000 shares of the stock in a transaction that occurred on Tuesday, September 9th. The stock was sold at an average price of $17.00, for a total value of $425,000.00. Following the completion of the sale, the director directly owned 1,127,049 shares of the company's stock, valued at approximately $19,159,833. This represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO John E. Kao sold 355,018 shares of the stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $5,825,845.38. Following the completion of the sale, the chief executive officer directly owned 4,533,568 shares of the company's stock, valued at $74,395,850.88. This represents a 7.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,262,077 shares of company stock valued at $19,805,859 in the last ninety days. Company insiders own 7.00% of the company's stock.

Alignment Healthcare Stock Performance

Alignment Healthcare stock traded down $0.03 during trading hours on Wednesday, reaching $16.45. 4,860,124 shares of the company were exchanged, compared to its average volume of 2,946,361. The firm has a market cap of $3.26 billion, a price-to-earnings ratio of -58.75 and a beta of 1.17. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The stock has a 50-day moving average of $14.32 and a 200 day moving average of $15.47. Alignment Healthcare, Inc. has a 12 month low of $8.82 and a 12 month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. During the same period in the prior year, the business earned ($0.13) earnings per share. Alignment Healthcare's revenue for the quarter was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on ALHC. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Zacks Research raised Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. Barclays raised Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price target for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. KeyCorp upgraded Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a report on Monday, August 25th. Finally, Wall Street Zen lowered Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $18.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.